Anthony Lau, MD
Neurological Surgery · Greenlawn, NYNPI 1679928691
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,925 of the $5,527 with a category attached, or 89.1%. 6 manufacturers reported payments, led by Spineology Inc. at 54.3% of the total. Reporting peaked in 2021 at $3,061 and has fallen 90.8% since, to $281 in 2022.
Across 10 payments — averaging $552.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineology Inc.$3K
- Depuy Synthes Products, Inc.$2K
- Medtronic$261
- Boston Scientific$163
- DJO, LLC$118
- Johnson & Johnson$61
What the payments were for
- Consulting fees$4,92589%
- Food & beverage$60211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineology Inc. | 1 | $3,000 |
| Depuy Synthes Products, Inc. | 1 | $1,925 |
| Medtronic | 3 | $261 |
| Boston Scientific | 1 | $163 |
| DJO, LLC | 2 | $118 |
| Johnson & Johnson | 2 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,527 in reported general payments places this provider in the 60th percentile of 446 neurological surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $259 |
| Methylprednisolone | 23 | $202 |
| Meloxicam | 27 | $179 |
| Naproxen | 22 | $121 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Greenlawn
- Ryan DenhaeseWilliamsville$1.9M
- J MoccoNew York$1.6M
- Adnan SiddiquiWilliamsville$1.5M
- Leo HopkinsBuffalo$1.2M
- Aziz Basem QandahNew Hartford$1.1M
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
- John PollinaWilliamsville$661K
- Michael GroffRochester$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.